{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:41:43Z","timestamp":1777480903857,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"3-4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Biomarkers"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>\n                    RNA-binding protein (RBP) plays pivotal roles in the malignant progression of cancer by regulating gene expression. In this paper, we aimed to develop RBP-based prognostic signature and identify critical hub RBPs in bladder cancer (BLCA). Firstly, a risk model based on differentially expressed RBP gens (DERBPs) between normal and tumor tissues was successfully established, which can predict the tumor stromal score and drug sensitivity. Then two another RBP risk models based on miRNA-correlated RBPs or lncRNA-correlated RBPs were also established, and\n                    <jats:italic toggle=\"yes\">RBMS3<\/jats:italic>\n                    was identified as the overlapping gene in the three models. Data from multiple bioinformatics databases revealed that\n                    <jats:italic toggle=\"yes\">RBMS3<\/jats:italic>\n                    was an independent prognostic factor for overall survival (OS), and was associated with an immunosuppressive tumor microenvironment (TME) in BLCA. Further, Single-cell RNA-Seq (scRNA-Seq) data and the human protein altas (HPA) database showed that RBMS3 expression (both mRNA and protein) were up-regulated in BLCA tumor and tumor stromal cells. Finally,\n                    <jats:italic toggle=\"yes\">RBMS3<\/jats:italic>\n                    was shown to be associated with worse response to BLCA immunotherapy. Overall, RBMS3 is a key prognostic RBP with TME remodeling function and may serve as a target for BLCA immunotherapy.\n                  <\/jats:p>","DOI":"10.3233\/cbm-230489","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T10:29:40Z","timestamp":1728642580000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancer"],"prefix":"10.1177","volume":"41","author":[{"given":"Tarimo Fredrick","family":"Praygod","sequence":"first","affiliation":[{"name":"Southern Medical University","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[{"name":"Southern Medical University","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[{"name":"Southern Medical University","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanlong","family":"Tan","sequence":"additional","affiliation":[{"name":"Southern Medical University","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Hu","sequence":"additional","affiliation":[{"name":"Southern Medical University","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[{"name":"Guangdong Polytechnic Normal University","place":["China"]},{"name":"Research Institute of Guangdong Polytechnic Normal University in Heyuan City","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0727-5"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14903.1"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3813"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092699"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.018"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111876"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2024.12543"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-230209"},{"key":"e_1_3_4_12_2","article-title":"ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment","volume":"103","author":"Pan W.","year":"2024","unstructured":"Pan W., Liu X., Liu S., ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment, Medicine (Baltimore) 103 (2024), e37590.","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580513"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.807622"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.751842"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.795781"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2021.01.021"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00992"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07930-5"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.574196"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq1069"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.05.021"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2638"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20201054"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.994019"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430"},{"key":"e_1_3_4_27_2","first-page":"2679","article-title":"Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer","volume":"6","author":"Zhang T.","year":"2016","unstructured":"Zhang T., Wu Y., Fang Z., Yan Q., Zhang S., Sun R., Khaliq J., Li Y., Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer, Am J Cancer Res 6 (2016), 2679\u20132689.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01731-z"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01428-1"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.05.003"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16458"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2020.02.003"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4291"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-3214"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","unstructured":"Wu G. Cao L. Zhu J. Tan Z. Tang M. Li Z. Hu Y. Yu R. Zhang S. Song L. Li J. Loss of RBMS3 confers platinum resistance in epithelial ovarian cancer via activation of miR-126-5p\/beta-catenin\/CBP signaling Clin Cancer Res 25 (2019) 1022\u20131035.","DOI":"10.1158\/1078-0432.CCR-18-2554"},{"key":"e_1_3_4_36_2","article-title":"Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration","volume":"10","author":"Yin T.","year":"2024","unstructured":"Yin T., Zhang Y., Zhao Y., Zhang X., Han S., Wang Y., Yang B., Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration, Heliyon 10 (2024), e30603.","journal-title":"Heliyon"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032866"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","unstructured":"Gornicki T. Lambrinow J. Mrozowska M. Podhorska-Okolow M. Dziegiel P. Grzegrzolka J. Role of RBMS3 novel potential regulator of the EMT phenomenon in physiological and pathological processes Int J Mol Sci 23 (2022).","DOI":"10.3390\/ijms231810875"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02030-x"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.011"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110260"}],"container-title":["Cancer Biomarkers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/CBM-230489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/CBM-230489","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/CBM-230489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:10Z","timestamp":1777385470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/CBM-230489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.3233\/CBM-230489"],"URL":"https:\/\/doi.org\/10.3233\/cbm-230489","relation":{},"ISSN":["1574-0153","1875-8592"],"issn-type":[{"value":"1574-0153","type":"print"},{"value":"1875-8592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"article-number":"CBM-230489"}}